<p>Summary of all variants identified in this study, the majority of which were found in primary tumors. R, recurrent; Chr, chromosome; NS, nonsynonymous; P, primary; SNV, single nucleotide variant.</p><p>Variants identified in Ion AmpliSeq Comprehensive Cancer Panel Genes.</p
<p>TCC = tumor cell content (%); VF = variant frequency; AR = amplicon reads</p><p>*: variant observ...
Multiple primary tumors (MPTs) affect a substantial proportion of cancer survivors and can result fr...
We conducted the largest investigation of predisposition variants in cancer to date, discovering 853...
Pathogenic and likely pathogenic variants by gene identified by the TruSight cancer sequencing panel...
The objective of this study was to investigate the mutational profiles of cancers arising in differe...
Glioblastoma (GBM) is an aggressive, malignant brain tumor typically resulting in death of the patie...
Use of next-generation sequencing to detect somatic variants in DNA extracted from formalin-fixed, p...
Biomarker discovery would be an important tool in advancing and utilizing the concept of precision a...
Background: Approximately 5–10% of all cancers are associated with hereditary cancer predisposition ...
<p>Variants were judged as known by their being listed in dbSNP. Variant counts for those unique to ...
<p>Genes containing variants and the associated sequencing platforms are shown. Most variants were a...
<p>NGS gene mutation detection using the Ion AmpliSeq Cancer Panel in colorectal carcinoma.</p
Cancer, like many common disorders, has a complex etiology, often with a strong genetic component an...
Colorectal cancer (CRC) is a disease that affects the large intestine (colon) and the rectum. In Ken...
<p>NGS gene mutation detection using the Ion AmpliSeq Cancer Panel in lung adenocarcinoma.</p
<p>TCC = tumor cell content (%); VF = variant frequency; AR = amplicon reads</p><p>*: variant observ...
Multiple primary tumors (MPTs) affect a substantial proportion of cancer survivors and can result fr...
We conducted the largest investigation of predisposition variants in cancer to date, discovering 853...
Pathogenic and likely pathogenic variants by gene identified by the TruSight cancer sequencing panel...
The objective of this study was to investigate the mutational profiles of cancers arising in differe...
Glioblastoma (GBM) is an aggressive, malignant brain tumor typically resulting in death of the patie...
Use of next-generation sequencing to detect somatic variants in DNA extracted from formalin-fixed, p...
Biomarker discovery would be an important tool in advancing and utilizing the concept of precision a...
Background: Approximately 5–10% of all cancers are associated with hereditary cancer predisposition ...
<p>Variants were judged as known by their being listed in dbSNP. Variant counts for those unique to ...
<p>Genes containing variants and the associated sequencing platforms are shown. Most variants were a...
<p>NGS gene mutation detection using the Ion AmpliSeq Cancer Panel in colorectal carcinoma.</p
Cancer, like many common disorders, has a complex etiology, often with a strong genetic component an...
Colorectal cancer (CRC) is a disease that affects the large intestine (colon) and the rectum. In Ken...
<p>NGS gene mutation detection using the Ion AmpliSeq Cancer Panel in lung adenocarcinoma.</p
<p>TCC = tumor cell content (%); VF = variant frequency; AR = amplicon reads</p><p>*: variant observ...
Multiple primary tumors (MPTs) affect a substantial proportion of cancer survivors and can result fr...
We conducted the largest investigation of predisposition variants in cancer to date, discovering 853...